17 results
·
18ms
·
Sources: EU EUDAMED, US FDA
HP-20, 30, 40, 50 & 60
FDA 510(k)
FDA Class 2
·Physical Medicine
ReLine
FDA UDI
Nuvasive, Inc.·00195377020871·RELINE-C Ti Rod, 3.5x100mm Straight
PILLING
FDA UDI
TELEFLEX INCORPORATED·24026704204339·
Life Instruments
FDA UDI
Life Instrument Corporation·M930784110030·Bayonet Knot Pusher 6" working length
APEX Knee System
FDA UDI
Omni Life Science, Inc.·00841690123668·Femoral Posterior Augment Trial, Size 1+, 10mm
APEX Revision Knee
FDA UDI
Omni Life Science, Inc.·00841690121282·Femoral Augment Posterior, Size 1+, 10mm
UniTip Catheter
FDA UDI
Unisensor AG·07640172971826·
Steri-Shield
FDA UDI
STRYKER CORPORATION·07613327625264·8 Zippered Toga with Peel Away Face Shield
T7Plus
FDA UDI
STRYKER CORPORATION·07613327466027·Zippered Toga with Peel Away Face Shield
OPTILITE C1 INACTIVATOR KIT
FDA 510(k)
FDA Class 2
·Immunology
NEXGEN POROUS, HA/TCP, UNCEMENTED FEMORAL AND TIBIAL BASEPLATE COMPONENTS
FDA 510(k)
FDA Class 2
·Orthopedic
HATCP STEM POR TIB PLT
FDA Adverse Event
Injury
·ZIMMER BIOMET, INC.·Product code MBH·March 5, 2024
NATURALYTE
FDA Adverse Event
Injury
·FRESENIUS MEDICAL CARE NORTH AMERICA·Product code KPO·May 13, 2014
MARYLAND BIPOLAR FORCEPS INSTRUMENT
FDA Adverse Event
Malfunction
·INTUITIVE SURGICAL,INC.·Product code NAY·November 20, 2012
EQ-5000 EQUATOR CONVECTIVE WARMER
FDA Adverse Event
Injury
·SMITHS MEDICAL ASD, INC.·Product code DWJ·September 16, 2010
T5 Hytrel Zipper Toga. Product Usage: The togas are intended to provide a barrier between the operating room and the members of the surgical team in order to help protect against contamination and/or exposure of infectious body fluids and harmful microorganisms.
FDA Enforcement
Class II
·Terminated·Stryker Instruments Div. of Stryker Corporation·June 20, 2012
Assurity Model Numbers: PM1240, PM2240; Assurity + Model Number: PM2260; Accent Model Numbers: PM1210, PM2210, PM1222, PM2212; Accent MRI Model Numbers: PM1224, PM2218, PM2224 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017